Rheumatoid Arthritis Clinical Trials in New York

Showing 3461-3480 of 3,596 trials

Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation

NCT00471133

The purpose of this study is to evaluate the safety and immunogenicity of a DNA vaccine encoding a melanosomal antigen in melanoma patients at risk for disease progression or recurrence. In this study, the vaccine will be administered intramuscularly using a device that applies brief electrical fields to the tissue at the site of injection (a technique known as electroporation). It is expected that this device will improve the delivery of the vaccine. This study is being performed to determine if this procedure can be administered safely and if it is capable of inducing immune responses to the vaccine.

Melanoma (Skin)Intraocular Melanoma

Ichor Medical Systems Incorporated24 participantsStarted Apr 2007

New York, New York, United States

COMPLETEDPhase 1< 1 mile

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer

NCT00025558

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Peripheral stem cell transplantation or bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining temozolomide, thiotepa, and carboplatin followed by peripheral stem cell transplantation or bone marrow transplantation in treating patients who have brain cancer.

Brain and Central Nervous System Tumors

NYU Langone HealthStarted Oct 2000

New York, New York, United States • Columbus, Ohio, United States • Philadelphia, Pennsylvania, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Fesoterodine "add-on" Male Overactive Bladder Study

NCT00546637

To evaluate the efficacy and safety of fesoterodine on overactive bladder symptom improvement when added to ongoing alpha blocker treatment.

Overactive Bladder Syndrome

Pfizer947 participantsStarted Nov 2007

Birmingham, Alabama, United States • Gilbert, Arizona, United States • Gilbert, Arizona, United States +134 more locations

Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer

Fesoterodine "add-on" Male Overactive Bladder Study

Rheumatoid Arthritis Trials in Other Cities

TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults

Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy

Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation

PREFER (Pacemaker Remote Follow-Up Evaluation and Review)

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Safety and Efficacy of MultiHance in Pediatric Patients

Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Evaluation of RTVue in Corneal Measurement

A Randomized Clinical Trial of Cognitive-Behavioral Treatment for Post-Traumatic Stress Disorders in Women

Insertion of an Intrauterine Device (IUD) After Medical Abortion

Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury

Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)

A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Other Conditions in New York